Issue 12, 2019

High affinity rigidified AT2 receptor ligands with indane scaffolds

Abstract

Rigidification of the isobutyl side chain of drug-like AT2 receptor agonists and antagonists that are structurally related to the first reported selective AT2 receptor agonist 1 (C21) delivered bioactive indane derivatives. Four enantiomer pairs were synthesized and the enantiomers were isolated in an optical purity >99%. The enantiomers 7a, 7b, 8a, 8b, 9a, 9b, 10a and 10b bind to the AT2 receptor with moderate (Ki = 54–223 nM) to high affinity (Ki = 2.2–7.0 nM). The enantiomer with positive optical rotation (+) exhibited the highest affinity at the receptor. The indane derivatives 7b and 10a are among the most potent AT2 receptor antagonists reported so far. As illustrated by the enantiomer pairs 7a/b and 10a/b, an alteration at the stereogenic center has a pronounced impact on the activation process of the AT2 receptor, and can convert agonists to antagonists and vice versa.

Graphical abstract: High affinity rigidified AT2 receptor ligands with indane scaffolds

Supplementary files

Article information

Article type
Research Article
Submitted
19 Aug 2019
Accepted
30 Oct 2019
First published
18 Nov 2019
This article is Open Access
Creative Commons BY-NC license

Med. Chem. Commun., 2019,10, 2146-2160

High affinity rigidified AT2 receptor ligands with indane scaffolds

C. Wallinder, C. Sköld, S. Sundholm, M. Guimond, S. Yahiaoui, G. Lindeberg, N. Gallo-Payet, M. Hallberg and M. Alterman, Med. Chem. Commun., 2019, 10, 2146 DOI: 10.1039/C9MD00402E

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements